Microbio Co Ltd - ESG Rating & Company Profile powered by AI
Jump to the bottom of this webpage for potential risks for Microbio Co Ltd based on sector, geography and marketcap. This report of Microbio Co Ltd uses data from across the web and also from available documents by Microbio Co Ltd. Full Sustainability analysis of Microbio Co Ltd are reached by registering for free.
Microbio Co Ltd in the Personal Products industry gained a UN SDG ESG Transparency Score of 6.1; made up of an environmental score of 4.6, social score of 5.7 and governance score of 8.0.
6.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | AKD SA | 8.0 | High |
| 1 | Kao Corp | 8.0 | High |
| 60 | Fuse Science Inc | 6.2 | High |
| 60 | Zhongzheng International Co Ltd | 6.2 | High |
| 69 | Microbio Co Ltd | 6.1 | High |
| 69 | BWX Ltd | 6.1 | High |
| 69 | Bajaj Consumer Care Ltd | 6.1 | High |
| ... | ... | ... | |
| 223 | Zhejiang Shouxiangu Pharmaceutical Co Ltd | 0.0 | Low |
| 223 | iPure Labs Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Microbio Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Microbio Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Microbio Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Microbio Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Microbio Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Microbio Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Microbio Co Ltd offer flexible work?
Sign up for free to unlockDoes Microbio Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Microbio Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Microbio Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Microbio Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Microbio Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Microbio Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Microbio Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Microbio Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Microbio Co Ltd disclose water use targets?
Sign up for free to unlockDoes Microbio Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Microbio Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Microbio Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Microbio Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Microbio Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Microbio Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Microbio Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Microbio Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Microbio Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Microbio Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Microbio Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Microbio Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Microbio Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Microbio Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Microbio Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Microbio Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Microbio Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Microbio Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Microbio Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Microbio Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Microbio Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for ameliorating fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia and menstrual discomfort. Its pre-clinical stage products include SNA-03 and SNA-07 for cancer immune therapy; SNP-630 to treat non-alcoholic steatohepatitis; FB918 for the treatment of non-allergic eosinophilic asthma; and SNS812 for Cov-flu. The company's Phase I clinical trial products consist of OB-318, an anti-cancer drug; MB-110 for the treatment of hepatitis C; SNP-810, an acetaminophen; FB317 to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria; and FB704A for the treatment of rheumatoid arthritis, cancer, cytokine storms, etc. It also offers FB825, which is in Phase II clinical trial for the treatment of atopic dermatitis, allergic asthma, hyper IgE syndrome, and food allergy. In addition, the company's Phase III clinical trial products comprise ON101 to treat diabetic foot ulcer; and MB-6 that acts as an adjuvant for metastatic colorectal cancer. Further, its discovery stage pipeline includes FB121 for AIDS; SNA01 to treat PD-1 related cancer; SNA02 for cancer immune therapy; and SNS01 for recurrent metastatic non-small cell lung cancer. Additionally, the company develops SNP-830 and SNP-840, a hepatotoxicity-free analgesic. It is also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was founded in 2000 and is based in Taipei, Taiwan.